title: A flexible protocol for the induction of recipient endometrial cycles in an oocyte donation programme.
abstract: Synchronization of the availability of good quality oocytes from donors and adequate endometrial maturation of recipients are very important for the success of an oocyte donation programme. A flexible protocol for the endometrial preparation of recipients is important in timing embryo transfer between days 17 and 19 of the cycle ('window of receptivity'). The purpose of this study was to evaluate the effect of the length of oestradiol administration to recipients on pregnancy outcome. Oestrogen administration was 8 mg/day, but its length varied prospectively from 6 to 27 days, followed by the addition of progesterone (100 mg daily i.m.) for 2-4 days according to the availability of good quality oocytes. Pregnancy outcome was evaluated regardless of age, indication for oocyte donation or number of embryos transferred per patient. The pregnancy rate per cycle was comparable when oestradiol was administered from 6 to 11 days before progesterone addition, while it dropped significantly thereafter. The variation in progesterone administration did not affect pregnancy outcome. These findings provide us with a greater flexibility by allowing us to vary oestradiol administration to recipients from 6 to 11 days prior to progesterone, reducing considerably, therefore, the need to cancel embryo transfer because of oocyte unavailability. Thus we can arrange to transfer embryos between days 17 and 19 of the recipient's cycle so as to obtain the best possible clinical outcome.
authors.affiliation: IVF Unit, Alexander Maternity Hospital, 1st Department of Obstetrics and Gynaecology, Athens University Medical School, Athens 115 28, Greece.
authors.forename: S
authors.initials: S
authors.lastname: Michalas
authors.forename: D
authors.initials: D
authors.lastname: Loutradis
authors.forename: P
authors.initials: P
authors.lastname: Drakakis
authors.forename: K
authors.initials: K
authors.lastname: Kallianidis
authors.forename: S
authors.initials: S
authors.lastname: Milingos
authors.forename: E
authors.initials: E
authors.lastname: Deligeoroglou
authors.forename: D
authors.initials: D
authors.lastname: Aravantinos
mesh_terms: D000328:Adult; D004624:Embryo Transfer; D004717:Endometrium / Q000187:drug effects / Q000502:physiology*; D004958:Estradiol / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D008875:Middle Aged; D018587:Oocyte Donation; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D011374:Progesterone; D004958:Estradiol; D005640:Follicle Stimulating Hormone